MedPath

The effect of ribose-cysteine on heart disease biomarkers

Not Applicable
Completed
Conditions
Cardiovascular
Oxidative Stress
Dyslipidaemia
Cardiovascular - Coronary heart disease
Registration Number
ACTRN12617000604303
Lead Sponsor
Prof Sally McCormick
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
60
Inclusion Criteria

Women who are
1.. 45-65 years of age
2. Post-menopausal
3. Not suffering from a pre-existing heart or liver condition

Exclusion Criteria

Women who
1. Smoke
2. Have a BMI > 35 kg/m2
3. Are Diabetic
4. Drink excessive amounts of alcohol i.e. >14 standard units per week
5. Are already taking ribose-cysteine or are on medications that can affect lipid levels i.e. statins

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath